Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.

Thompson MA, Stumph J, Henrickson SE, Rosenwald A, Wang Q, Olson S, Brandt SJ, Roberts J, Zhang X, Shyr Y, Kinney MC.

Hum Pathol. 2005 May;36(5):494-504.

PMID:
15948116
2.

Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.

Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG.

Leukemia. 2000 Sep;14(9):1533-59. Review.

PMID:
10994999
3.

Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.

Kutok JL, Aster JC.

J Clin Oncol. 2002 Sep 1;20(17):3691-702. Review.

PMID:
12202671
4.

The anaplastic lymphoma kinase in the pathogenesis of cancer.

Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G.

Nat Rev Cancer. 2008 Jan;8(1):11-23. Review.

PMID:
18097461
5.

[Anaplastic large-cell lymphoma: review].

Kodet R, Mrhalová M, Krsková L, Stejskalová E.

Cesk Patol. 2003 Jul;39(3):102-14. Review. Czech.

PMID:
14631806
6.

ALK-positive lymphoma: a single disease with a broad spectrum of morphology.

Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugières L, Terrier-Lacombe MJ, Haralambieva E, Pulford K, Pileri S, Morris SW, Mason DY, Delsol G.

Blood. 1998 Mar 15;91(6):2076-84. Review.

8.

Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.

Xing X, Feldman AL.

Adv Anat Pathol. 2015 Jan;22(1):29-49. doi: 10.1097/PAP.0000000000000047. Review.

PMID:
25461779
9.

[Molecular abnormalities in lymphomas].

Delsol G.

Bull Cancer. 2010 Nov;97(11):1347-64. doi: 10.1684/bdc.2010.1214. Review. French.

PMID:
21084243
10.

ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.

Oschlies I, Lisfeld J, Lamant L, Nakazawa A, d'Amore ES, Hansson U, Hebeda K, Simonitsch-Klupp I, Maldyk J, Müllauer L, Tinguely M, Stücker M, Ledeley MC, Siebert R, Reiter A, Brugières L, Klapper W, Woessmann W.

Haematologica. 2013 Jan;98(1):50-6. doi: 10.3324/haematol.2012.065664. Epub 2012 Jul 6. Review.

11.

Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma.

Tabbò F, Ponzoni M, Rabadan R, Bertoni F, Inghirami G; European T-cell Lymphoma Study Group.

Curr Opin Hematol. 2013 Jul;20(4):374-81. doi: 10.1097/MOH.0b013e3283623c07. Review.

12.

Primary pancreatic anaplastic large cell lymphoma, ALK negative: a case report.

Savopoulos CG, Tsesmeli NE, Kaiafa GD, Zantidis AT, Bobos MT, Hatzitolios AI, Papavramidis ST, Kostopoulos IS.

World J Gastroenterol. 2005 Oct 21;11(39):6221-4. Review.

13.

ALK-driven tumors and targeted therapy: focus on crizotinib.

Murga-Zamalloa C, Lim MS.

Pharmgenomics Pers Med. 2014 Mar 20;7:87-94. doi: 10.2147/PGPM.S37504. eCollection 2014. Review.

14.

Anaplastic large cell lymphoma in paediatric and young adult patients.

Turner SD, Lamant L, Kenner L, Brugières L.

Br J Haematol. 2016 May;173(4):560-72. doi: 10.1111/bjh.13958. Epub 2016 Feb 23. Review.

PMID:
26913827
15.

ALK-positive cancer: still a growing entity.

Gorczyński A, Prełowska M, Adam P, Czapiewski P, Biernat W.

Future Oncol. 2014 Feb;10(2):305-21. doi: 10.2217/fon.13.184. Review.

PMID:
24490615
16.

Anaplastic lymphoma kinase: activating mechanisms and signaling pathways.

Pizzi M, Gaudiano M, Todaro M, Inghirami G.

Front Biosci (Schol Ed). 2015 Jun 1;7:283-305. Review.

PMID:
25961703
17.

Anaplastic Lymphoma Kinase as a Cancer Target in Pediatric Malignancies.

Mossé YP.

Clin Cancer Res. 2016 Feb 1;22(3):546-52. doi: 10.1158/1078-0432.CCR-14-1100. Epub 2015 Oct 26. Review.

PMID:
26503946
Items per page

Supplemental Content

Write to the Help Desk